KLK3 and prostate cancer: In the LNCaP intratibially injected prostate cancer model mimicking CRPC with bone metastases, combination treatment with radium-223 and an ATR inhibitor increased intratumoral levels of DNA damage and decreased total tumor lesion area and PSA values suggesting the potential of disrupting the vicious cycle of bone metastasis [80].